Interactions of “Bora-Penicilloates” with Serine β‑Lactamases and DD-Peptidases

Specific boronic acids are generally powerful tetrahedral intermediate/transition state analogue inhibitors of serine amidohydrolases. This group of enzymes includes bacterial β-lactamases and DD-peptidases where there has been considerable development of boronic acid inhibitors. This paper describe...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biochemistry (Easton) 2014-10, Vol.53 (41), p.6530-6538
Hauptverfasser: Dzhekieva, Liudmila, Adediran, S. A, Pratt, R. F
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 6538
container_issue 41
container_start_page 6530
container_title Biochemistry (Easton)
container_volume 53
creator Dzhekieva, Liudmila
Adediran, S. A
Pratt, R. F
description Specific boronic acids are generally powerful tetrahedral intermediate/transition state analogue inhibitors of serine amidohydrolases. This group of enzymes includes bacterial β-lactamases and DD-peptidases where there has been considerable development of boronic acid inhibitors. This paper describes the synthesis, determination of the inhibitory activity, and analysis of the results from two α-(2-thiazolidinyl) boronic acids that are closer analogues of particular tetrahedral intermediates involved in β-lactamase and DD-peptidase catalysis than those previously described. One of them, 2-[1-(dihydroxyboranyl)­(2-phenylacetamido)­methyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid, is a direct analogue of the deacylation tetrahedral intermediates of these enzymes. These compounds are micromolar inhibitors of class C β-lactamases but, very unexpectedly, not inhibitors of class A β-lactamases. We rationalize the latter result on the basis of a new mechanism of boronic acid inhibition of the class A enzymes. A stable inhibitory complex is not accessible because of the instability of an intermediate on its pathway of formation. The new boronic acids also do not inhibit bacterial DD-peptidases (penicillin-binding proteins). This result strongly supports a central feature of a previously proposed mechanism of action of β-lactam antibiotics, where deacylation of β-lactam-derived acyl-enzymes is not possible because of unfavorable steric interactions.
doi_str_mv 10.1021/bi500970f
format Article
fullrecord <record><control><sourceid>acs_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4204886</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>f66483232</sourcerecordid><originalsourceid>FETCH-LOGICAL-a405t-d788c9896f48a265681dda6e4a2b3bd491510193445bf60cf5762988d596c97b3</originalsourceid><addsrcrecordid>eNptkE1OwzAQhS0EoqWw4AIoGxYsAmPHduwNErT8VKoEEj_byEkcatQ6lZ2C2PUK7OESHIRD9CS4KlQgsRrN-L1vPA-hXQyHGAg-yg0DkClUa6iNGYGYSsnWURsAeEwkhxba8v4xtBRSuolahCVAWMrb6L5vG-1U0Zja-qiuovns7bR2Kr7W1hRmNKpVo_189h49m2YY3WhnrI4-P-az10FwqbHy2kfKllGvFzyTxpSLyTbaqNTI653v2kF352e33ct4cHXR754MYkWBNXGZClFIIXlFhSKccYHLUnFNFcmTvKQSMwxYJpSyvOJQVOHPRApRMskLmeZJBx0vuZNpPtZloW3j1CibODNW7iWrlcn-vlgzzB7qp4wSoELwADhYAgpXe-90tfJiyBbhZqtwg3bv97KV8ifNINhfClThs8d66my4_R_QF55AhME</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Interactions of “Bora-Penicilloates” with Serine β‑Lactamases and DD-Peptidases</title><source>MEDLINE</source><source>American Chemical Society Journals</source><creator>Dzhekieva, Liudmila ; Adediran, S. A ; Pratt, R. F</creator><creatorcontrib>Dzhekieva, Liudmila ; Adediran, S. A ; Pratt, R. F</creatorcontrib><description>Specific boronic acids are generally powerful tetrahedral intermediate/transition state analogue inhibitors of serine amidohydrolases. This group of enzymes includes bacterial β-lactamases and DD-peptidases where there has been considerable development of boronic acid inhibitors. This paper describes the synthesis, determination of the inhibitory activity, and analysis of the results from two α-(2-thiazolidinyl) boronic acids that are closer analogues of particular tetrahedral intermediates involved in β-lactamase and DD-peptidase catalysis than those previously described. One of them, 2-[1-(dihydroxyboranyl)­(2-phenylacetamido)­methyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid, is a direct analogue of the deacylation tetrahedral intermediates of these enzymes. These compounds are micromolar inhibitors of class C β-lactamases but, very unexpectedly, not inhibitors of class A β-lactamases. We rationalize the latter result on the basis of a new mechanism of boronic acid inhibition of the class A enzymes. A stable inhibitory complex is not accessible because of the instability of an intermediate on its pathway of formation. The new boronic acids also do not inhibit bacterial DD-peptidases (penicillin-binding proteins). This result strongly supports a central feature of a previously proposed mechanism of action of β-lactam antibiotics, where deacylation of β-lactam-derived acyl-enzymes is not possible because of unfavorable steric interactions.</description><identifier>ISSN: 0006-2960</identifier><identifier>EISSN: 1520-4995</identifier><identifier>DOI: 10.1021/bi500970f</identifier><identifier>PMID: 25302576</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Acylation - drug effects ; Anti-Bacterial Agents - chemistry ; Anti-Bacterial Agents - metabolism ; Anti-Bacterial Agents - pharmacology ; Bacterial Proteins - antagonists &amp; inhibitors ; Bacterial Proteins - chemistry ; Bacterial Proteins - metabolism ; beta-Lactamase Inhibitors - chemistry ; beta-Lactamase Inhibitors - metabolism ; beta-Lactamase Inhibitors - pharmacology ; beta-Lactamases - chemistry ; beta-Lactamases - metabolism ; Biocatalysis - drug effects ; Boronic Acids - chemistry ; Boronic Acids - metabolism ; Boronic Acids - pharmacology ; Catalytic Domain ; Drug Design ; Isoenzymes - antagonists &amp; inhibitors ; Isoenzymes - chemistry ; Isoenzymes - metabolism ; Kinetics ; Membrane Proteins - antagonists &amp; inhibitors ; Membrane Proteins - chemistry ; Membrane Proteins - metabolism ; Models, Molecular ; Molecular Conformation ; Penicillanic Acid - analogs &amp; derivatives ; Penicillanic Acid - chemistry ; Penicillanic Acid - metabolism ; Penicillanic Acid - pharmacology ; Penicillin-Binding Proteins - antagonists &amp; inhibitors ; Penicillin-Binding Proteins - chemistry ; Penicillin-Binding Proteins - metabolism ; Serine - chemistry ; Serine Endopeptidases - chemistry ; Serine Endopeptidases - metabolism ; Serine Proteinase Inhibitors - chemistry ; Serine Proteinase Inhibitors - metabolism ; Serine Proteinase Inhibitors - pharmacology</subject><ispartof>Biochemistry (Easton), 2014-10, Vol.53 (41), p.6530-6538</ispartof><rights>Copyright © 2014 American Chemical Society</rights><rights>Copyright © 2014 American Chemical Society 2014 American Chemical Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a405t-d788c9896f48a265681dda6e4a2b3bd491510193445bf60cf5762988d596c97b3</citedby><cites>FETCH-LOGICAL-a405t-d788c9896f48a265681dda6e4a2b3bd491510193445bf60cf5762988d596c97b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/bi500970f$$EPDF$$P50$$Gacs$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/bi500970f$$EHTML$$P50$$Gacs$$Hfree_for_read</linktohtml><link.rule.ids>230,315,781,785,886,2766,27077,27925,27926,56739,56789</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25302576$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dzhekieva, Liudmila</creatorcontrib><creatorcontrib>Adediran, S. A</creatorcontrib><creatorcontrib>Pratt, R. F</creatorcontrib><title>Interactions of “Bora-Penicilloates” with Serine β‑Lactamases and DD-Peptidases</title><title>Biochemistry (Easton)</title><addtitle>Biochemistry</addtitle><description>Specific boronic acids are generally powerful tetrahedral intermediate/transition state analogue inhibitors of serine amidohydrolases. This group of enzymes includes bacterial β-lactamases and DD-peptidases where there has been considerable development of boronic acid inhibitors. This paper describes the synthesis, determination of the inhibitory activity, and analysis of the results from two α-(2-thiazolidinyl) boronic acids that are closer analogues of particular tetrahedral intermediates involved in β-lactamase and DD-peptidase catalysis than those previously described. One of them, 2-[1-(dihydroxyboranyl)­(2-phenylacetamido)­methyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid, is a direct analogue of the deacylation tetrahedral intermediates of these enzymes. These compounds are micromolar inhibitors of class C β-lactamases but, very unexpectedly, not inhibitors of class A β-lactamases. We rationalize the latter result on the basis of a new mechanism of boronic acid inhibition of the class A enzymes. A stable inhibitory complex is not accessible because of the instability of an intermediate on its pathway of formation. The new boronic acids also do not inhibit bacterial DD-peptidases (penicillin-binding proteins). This result strongly supports a central feature of a previously proposed mechanism of action of β-lactam antibiotics, where deacylation of β-lactam-derived acyl-enzymes is not possible because of unfavorable steric interactions.</description><subject>Acylation - drug effects</subject><subject>Anti-Bacterial Agents - chemistry</subject><subject>Anti-Bacterial Agents - metabolism</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Bacterial Proteins - antagonists &amp; inhibitors</subject><subject>Bacterial Proteins - chemistry</subject><subject>Bacterial Proteins - metabolism</subject><subject>beta-Lactamase Inhibitors - chemistry</subject><subject>beta-Lactamase Inhibitors - metabolism</subject><subject>beta-Lactamase Inhibitors - pharmacology</subject><subject>beta-Lactamases - chemistry</subject><subject>beta-Lactamases - metabolism</subject><subject>Biocatalysis - drug effects</subject><subject>Boronic Acids - chemistry</subject><subject>Boronic Acids - metabolism</subject><subject>Boronic Acids - pharmacology</subject><subject>Catalytic Domain</subject><subject>Drug Design</subject><subject>Isoenzymes - antagonists &amp; inhibitors</subject><subject>Isoenzymes - chemistry</subject><subject>Isoenzymes - metabolism</subject><subject>Kinetics</subject><subject>Membrane Proteins - antagonists &amp; inhibitors</subject><subject>Membrane Proteins - chemistry</subject><subject>Membrane Proteins - metabolism</subject><subject>Models, Molecular</subject><subject>Molecular Conformation</subject><subject>Penicillanic Acid - analogs &amp; derivatives</subject><subject>Penicillanic Acid - chemistry</subject><subject>Penicillanic Acid - metabolism</subject><subject>Penicillanic Acid - pharmacology</subject><subject>Penicillin-Binding Proteins - antagonists &amp; inhibitors</subject><subject>Penicillin-Binding Proteins - chemistry</subject><subject>Penicillin-Binding Proteins - metabolism</subject><subject>Serine - chemistry</subject><subject>Serine Endopeptidases - chemistry</subject><subject>Serine Endopeptidases - metabolism</subject><subject>Serine Proteinase Inhibitors - chemistry</subject><subject>Serine Proteinase Inhibitors - metabolism</subject><subject>Serine Proteinase Inhibitors - pharmacology</subject><issn>0006-2960</issn><issn>1520-4995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>N~.</sourceid><sourceid>EIF</sourceid><recordid>eNptkE1OwzAQhS0EoqWw4AIoGxYsAmPHduwNErT8VKoEEj_byEkcatQ6lZ2C2PUK7OESHIRD9CS4KlQgsRrN-L1vPA-hXQyHGAg-yg0DkClUa6iNGYGYSsnWURsAeEwkhxba8v4xtBRSuolahCVAWMrb6L5vG-1U0Zja-qiuovns7bR2Kr7W1hRmNKpVo_189h49m2YY3WhnrI4-P-az10FwqbHy2kfKllGvFzyTxpSLyTbaqNTI653v2kF352e33ct4cHXR754MYkWBNXGZClFIIXlFhSKccYHLUnFNFcmTvKQSMwxYJpSyvOJQVOHPRApRMskLmeZJBx0vuZNpPtZloW3j1CibODNW7iWrlcn-vlgzzB7qp4wSoELwADhYAgpXe-90tfJiyBbhZqtwg3bv97KV8ifNINhfClThs8d66my4_R_QF55AhME</recordid><startdate>20141021</startdate><enddate>20141021</enddate><creator>Dzhekieva, Liudmila</creator><creator>Adediran, S. A</creator><creator>Pratt, R. F</creator><general>American Chemical Society</general><scope>N~.</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20141021</creationdate><title>Interactions of “Bora-Penicilloates” with Serine β‑Lactamases and DD-Peptidases</title><author>Dzhekieva, Liudmila ; Adediran, S. A ; Pratt, R. F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a405t-d788c9896f48a265681dda6e4a2b3bd491510193445bf60cf5762988d596c97b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Acylation - drug effects</topic><topic>Anti-Bacterial Agents - chemistry</topic><topic>Anti-Bacterial Agents - metabolism</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Bacterial Proteins - antagonists &amp; inhibitors</topic><topic>Bacterial Proteins - chemistry</topic><topic>Bacterial Proteins - metabolism</topic><topic>beta-Lactamase Inhibitors - chemistry</topic><topic>beta-Lactamase Inhibitors - metabolism</topic><topic>beta-Lactamase Inhibitors - pharmacology</topic><topic>beta-Lactamases - chemistry</topic><topic>beta-Lactamases - metabolism</topic><topic>Biocatalysis - drug effects</topic><topic>Boronic Acids - chemistry</topic><topic>Boronic Acids - metabolism</topic><topic>Boronic Acids - pharmacology</topic><topic>Catalytic Domain</topic><topic>Drug Design</topic><topic>Isoenzymes - antagonists &amp; inhibitors</topic><topic>Isoenzymes - chemistry</topic><topic>Isoenzymes - metabolism</topic><topic>Kinetics</topic><topic>Membrane Proteins - antagonists &amp; inhibitors</topic><topic>Membrane Proteins - chemistry</topic><topic>Membrane Proteins - metabolism</topic><topic>Models, Molecular</topic><topic>Molecular Conformation</topic><topic>Penicillanic Acid - analogs &amp; derivatives</topic><topic>Penicillanic Acid - chemistry</topic><topic>Penicillanic Acid - metabolism</topic><topic>Penicillanic Acid - pharmacology</topic><topic>Penicillin-Binding Proteins - antagonists &amp; inhibitors</topic><topic>Penicillin-Binding Proteins - chemistry</topic><topic>Penicillin-Binding Proteins - metabolism</topic><topic>Serine - chemistry</topic><topic>Serine Endopeptidases - chemistry</topic><topic>Serine Endopeptidases - metabolism</topic><topic>Serine Proteinase Inhibitors - chemistry</topic><topic>Serine Proteinase Inhibitors - metabolism</topic><topic>Serine Proteinase Inhibitors - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dzhekieva, Liudmila</creatorcontrib><creatorcontrib>Adediran, S. A</creatorcontrib><creatorcontrib>Pratt, R. F</creatorcontrib><collection>American Chemical Society (ACS) Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Biochemistry (Easton)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dzhekieva, Liudmila</au><au>Adediran, S. A</au><au>Pratt, R. F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Interactions of “Bora-Penicilloates” with Serine β‑Lactamases and DD-Peptidases</atitle><jtitle>Biochemistry (Easton)</jtitle><addtitle>Biochemistry</addtitle><date>2014-10-21</date><risdate>2014</risdate><volume>53</volume><issue>41</issue><spage>6530</spage><epage>6538</epage><pages>6530-6538</pages><issn>0006-2960</issn><eissn>1520-4995</eissn><abstract>Specific boronic acids are generally powerful tetrahedral intermediate/transition state analogue inhibitors of serine amidohydrolases. This group of enzymes includes bacterial β-lactamases and DD-peptidases where there has been considerable development of boronic acid inhibitors. This paper describes the synthesis, determination of the inhibitory activity, and analysis of the results from two α-(2-thiazolidinyl) boronic acids that are closer analogues of particular tetrahedral intermediates involved in β-lactamase and DD-peptidase catalysis than those previously described. One of them, 2-[1-(dihydroxyboranyl)­(2-phenylacetamido)­methyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid, is a direct analogue of the deacylation tetrahedral intermediates of these enzymes. These compounds are micromolar inhibitors of class C β-lactamases but, very unexpectedly, not inhibitors of class A β-lactamases. We rationalize the latter result on the basis of a new mechanism of boronic acid inhibition of the class A enzymes. A stable inhibitory complex is not accessible because of the instability of an intermediate on its pathway of formation. The new boronic acids also do not inhibit bacterial DD-peptidases (penicillin-binding proteins). This result strongly supports a central feature of a previously proposed mechanism of action of β-lactam antibiotics, where deacylation of β-lactam-derived acyl-enzymes is not possible because of unfavorable steric interactions.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>25302576</pmid><doi>10.1021/bi500970f</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0006-2960
ispartof Biochemistry (Easton), 2014-10, Vol.53 (41), p.6530-6538
issn 0006-2960
1520-4995
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4204886
source MEDLINE; American Chemical Society Journals
subjects Acylation - drug effects
Anti-Bacterial Agents - chemistry
Anti-Bacterial Agents - metabolism
Anti-Bacterial Agents - pharmacology
Bacterial Proteins - antagonists & inhibitors
Bacterial Proteins - chemistry
Bacterial Proteins - metabolism
beta-Lactamase Inhibitors - chemistry
beta-Lactamase Inhibitors - metabolism
beta-Lactamase Inhibitors - pharmacology
beta-Lactamases - chemistry
beta-Lactamases - metabolism
Biocatalysis - drug effects
Boronic Acids - chemistry
Boronic Acids - metabolism
Boronic Acids - pharmacology
Catalytic Domain
Drug Design
Isoenzymes - antagonists & inhibitors
Isoenzymes - chemistry
Isoenzymes - metabolism
Kinetics
Membrane Proteins - antagonists & inhibitors
Membrane Proteins - chemistry
Membrane Proteins - metabolism
Models, Molecular
Molecular Conformation
Penicillanic Acid - analogs & derivatives
Penicillanic Acid - chemistry
Penicillanic Acid - metabolism
Penicillanic Acid - pharmacology
Penicillin-Binding Proteins - antagonists & inhibitors
Penicillin-Binding Proteins - chemistry
Penicillin-Binding Proteins - metabolism
Serine - chemistry
Serine Endopeptidases - chemistry
Serine Endopeptidases - metabolism
Serine Proteinase Inhibitors - chemistry
Serine Proteinase Inhibitors - metabolism
Serine Proteinase Inhibitors - pharmacology
title Interactions of “Bora-Penicilloates” with Serine β‑Lactamases and DD-Peptidases
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T15%3A10%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-acs_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Interactions%20of%20%E2%80%9CBora-Penicilloates%E2%80%9D%20with%20Serine%20%CE%B2%E2%80%91Lactamases%20and%20DD-Peptidases&rft.jtitle=Biochemistry%20(Easton)&rft.au=Dzhekieva,%20Liudmila&rft.date=2014-10-21&rft.volume=53&rft.issue=41&rft.spage=6530&rft.epage=6538&rft.pages=6530-6538&rft.issn=0006-2960&rft.eissn=1520-4995&rft_id=info:doi/10.1021/bi500970f&rft_dat=%3Cacs_pubme%3Ef66483232%3C/acs_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/25302576&rfr_iscdi=true